Zosuquidar trihydrochloride
CAS No. 167465-36-3
Zosuquidar trihydrochloride ( LY-335979 trihydrochloride )
Catalog No. M12557 CAS No. 167465-36-3
A potent P-glycoprotein (P-gp) inhibitor with Ki of 60 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 36 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 81 | In Stock |
|
50MG | 340 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZosuquidar trihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent P-glycoprotein (P-gp) inhibitor with Ki of 60 nM.
-
DescriptionA potent P-glycoprotein (P-gp) inhibitor with Ki of 60 nM; fully restores sensitivity to vinblastine, doxorubicin, etoposide, and Taxol in CEM/VLB100 cells at 0.1 uM; enhances the antitumor activity of Taxol in a MDR human non-small cell lung carcinoma nude mouse xenograft model.Blood Cancer Phase 3 Discontinued
-
SynonymsLY-335979 trihydrochloride
-
PathwayMembrane Transporter/Ion Channel
-
TargetP-glycoprotein
-
RecptorP-gp(P-glycoprotein)
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number167465-36-3
-
Formula Weight636.99
-
Molecular FormulaC32H34Cl3F2N3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESFC1([C@H]2[C@@H]1C3=C([C@@H](C4=CC=CC=C42)N5CCN(CC5)C[C@H](COC6=C7C=CC=NC7=CC=C6)O)C=CC=C3)F.Cl.Cl.Cl
-
Chemical Name1-Piperazineethanol, 4-[(1a.alpha.,6.alpha.,10b.alpha.)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-.alpha.-[(5-quinolinyloxy)methyl]-, hydrochloride (1:3), (.alpha.R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Slate DL, et al. Anticancer Res. 1995 May-Jun;15(3):811-4.
2. Dantzig AH, et al. Cancer Res. 1996 Sep 15;56(18):4171-9.
3. Dantzig AH, et al. J Pharmacol Exp Ther. 1999 Aug;290(2):854-62.
2. Dantzig AH, et al. Cancer Res. 1996 Sep 15;56(18):4171-9.
3. Dantzig AH, et al. J Pharmacol Exp Ther. 1999 Aug;290(2):854-62.
molnova catalog
related products
-
Zosuquidar trihydroc...
A potent P-glycoprotein (P-gp) inhibitor with Ki of 60 nM.
-
Dofequidar
A novel, orally active quinoline compound that can reverse P-glycoprotein (P-gp)-mediated MDR.
-
Tariquidar methanesu...
A potent, specific P-gp inhibitor with Kd of 5.1 nM.